There's a "kind of dry eye renaissance" under way, and it's all thanks to advances in diagnosis and treatment, according to a post at the American Academy of Ophthalmology.
"We've entered an era of innovative management for this common condition'a kind of dry eye renaissance,'" writes Dr. Nancy Kalish of the University of Maryland School of Medicine.
"Progress is essential because dry eye's incidence is growing....
It's also driven by our population's advancing age, irritants such as contact lens wear and extended screen time, and an awareness among patients that they don't have to live scratchiness, burning, or blurred vision."
Kalish notes that dry eye is on the rise not only because of the aging population, but also because of an increase in screen time and contact lens wear, as well as an awareness that those who don't have tears in their eyes don't have to live with them.
There are currently several treatments on the market for dry eye, but they're not always effective.
"Only by staying informed about the growing spectrum of products can we do our best to manage this intractable condition," Kalish writes.
There are currently no FDA-approved drugs for dry eye,
A customized collection of grant news from foundations and the federal government from around the Web.
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.